Navigation Links
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
Date:9/28/2007

lications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational science and technology expertise to rapidly develop an enviable late-stage pipeline of several novel reproduction hormone analogs for wide-ranging therapeutic use initially in bovine and equine species. AspenBio Pharma continues to advance the development and testing of its two first-generation blood-based human diagnostic tests designed to rapidly help diagnose or rule out appendicitis in patients complaining of abdominal pain. For more information, please visit: http://www.aspenbiopharma.com.

Forward Looking Statements

This news release includes "forward looking statements" of AspenBio Pharma, Inc. ("APPY") as defined by the Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical fact, included in the press release that address activities, events or developments that APPY believes or anticipates will or may occur in the future are forward- looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors APPY believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of APPY. Investors are cautioned that any such statements are not guarantees of future performance. Actual results or developments may differ materially from those projected in the forward-looking statements as a result of many factors, including the ability to successfully complete the development of, obtain FDA approval for and generate revenues from the appendicitis test and other new products, execute agreements required to successfully advance the company's objectives, retain the scientific management
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Inc. (NASDAQ: HOLX ) announced today the Company,s ... 27, 2015.  Quarterly revenues of $693.9 million increased 9.7% ... currency basis.  GAAP earnings per share (EPS) of $0.10 ... "Our third quarter financial results demonstrate the ... that can grow sustainably on both the top and ...
(Date:7/29/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology and medical device industries, with operations ... the United States , today announced that it ... after the New York Stock Exchange closes on Thursday, ... 14, 2015 Shanghai time). The earnings release will be ...
(Date:7/29/2015)... SAN DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... ended June 30, 2015. For the second quarter of 2015, the ... per share, compared to a net loss of $13.4 million, or ... the six months ended June 30, 2015, the Company reported a ... compared to net loss of $25.2 million, or $0.35 loss per ...
Breaking Medicine Technology:Hologic Announces Financial Results for Third Quarter of Fiscal 2015 2Hologic Announces Financial Results for Third Quarter of Fiscal 2015 3Hologic Announces Financial Results for Third Quarter of Fiscal 2015 4Hologic Announces Financial Results for Third Quarter of Fiscal 2015 5Hologic Announces Financial Results for Third Quarter of Fiscal 2015 6Hologic Announces Financial Results for Third Quarter of Fiscal 2015 7Hologic Announces Financial Results for Third Quarter of Fiscal 2015 8Hologic Announces Financial Results for Third Quarter of Fiscal 2015 9Hologic Announces Financial Results for Third Quarter of Fiscal 2015 10Hologic Announces Financial Results for Third Quarter of Fiscal 2015 11Hologic Announces Financial Results for Third Quarter of Fiscal 2015 12Hologic Announces Financial Results for Third Quarter of Fiscal 2015 13Hologic Announces Financial Results for Third Quarter of Fiscal 2015 14Hologic Announces Financial Results for Third Quarter of Fiscal 2015 15Hologic Announces Financial Results for Third Quarter of Fiscal 2015 16Hologic Announces Financial Results for Third Quarter of Fiscal 2015 17Hologic Announces Financial Results for Third Quarter of Fiscal 2015 18Hologic Announces Financial Results for Third Quarter of Fiscal 2015 19Hologic Announces Financial Results for Third Quarter of Fiscal 2015 20Hologic Announces Financial Results for Third Quarter of Fiscal 2015 21Hologic Announces Financial Results for Third Quarter of Fiscal 2015 22Hologic Announces Financial Results for Third Quarter of Fiscal 2015 23Hologic Announces Financial Results for Third Quarter of Fiscal 2015 24Hologic Announces Financial Results for Third Quarter of Fiscal 2015 25WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9
... Draeger Safety Inc. announced today that ... of Draeger emergency responder equipment in thirteen western ... , , ... sales, delivery and service for all Draeger products sold to state and local municipal ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today the completion of its acquisition of ... services, located in Austin, Texas . , ... On July 12, 2010 , Endo acquired HealthTronics through a tender offer and ... , , ...
Cached Medicine Technology:Draeger Announces Partnership With L. N. Curtis & sons to Distribute Emergency Responder Equipment 2Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc. 2Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc. 3Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc. 4Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc. 5
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide ... St. John’s Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh ... more than 25 years of healthcare leadership experience, Walsh is an expert in organizational ...
(Date:7/30/2015)... Beverly Hills, CA (PRWEB) , ... July 30, 2015 , ... ... safety of the Argus II retinal implant, more commonly known as the “bionic eye,” ... II as a safe and viable tool for patients facing or already affected by ...
(Date:7/30/2015)... ... , ... HEALTHCAREfirst , the leading provider of cloud-based software, services and ... a free webinar detailing the 2016 proposed rule from CMS for home health. , ... of Regulatory Affairs for the National Association for Home Care and Hospice (NAHC), and ...
(Date:7/30/2015)... ... July 30, 2015 , ... The renowned ... grants in its history of funding brain aneurysm research. , Each year, ... life’s work toward scientific research directed at early detection, improved treatment modalities, and ...
(Date:7/30/2015)... Orem, UT (PRWEB) , ... July 30, 2015 , ... When trying to gain weight, many people place a lot ... the amount of calories that need to be consumed. However, another key component to successful ... to gain weight. To assist with this, CB-1 Weight Gainer gives three tips on ...
Breaking Medicine News(10 mins):Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
... , , MOUNTAIN VIEW, Calif., Sept. 16 ... Hospital CEO, Ken Graham, will provide insight on health care reform at ... 17 at 7:15 a.m. at the Rotary Summit Center. , , ... contribute to the health care reform debate. El Camino Hospital, a non-profit ...
... , REDMOND, Wash., Sept. 16 It,s ... seats in classrooms and lecture halls because of unfortunate outbreaks of ... to the U.S. Department of Education and schools and universities across ... educators stay connected with their students and continue the learning process ...
... , www.intelligenthospitals.com , , WINNIPEG, Sept. ... of pharmacy across North America, 77% of those looking ... (Robotic Intravenous Automation) - a self-contained unit for filling ... Systems) - as a vendor under consideration. The survey ...
... , , WASHINGTON, Sept. 16 ... CEO of the American Legacy Foundation: , , The ... U.S. House of Representatives who have worked tirelessly to protect Capitol Hill ... , On Thursday, the House,s last two indoor smoking ...
... , NEW YORK, Sept. 16 HMS today announced ... of Human Services (DHS) to provide additional third-party liability services. With ... to 39 state Medicaid agencies. , , "Under ... Billi Jo Zielinski, Assistant Commissioner of Health Care. "This will help ...
... , WASHINGTON, Sept. 16 The U.S. Food and ... a boxed warning regarding the injectable form of the drug. The ... the risk of serious tissue injury when this drug is administered ... new boxed warning for this product, which is used as a ...
Cached Medicine News:Health News:El Camino Hospital Provides Local Perspective on Health Care Reform and Innovation at Silicon Valley Healthcare CEO Summit 2Health News:Microsoft Gives Teachers Free Resources to Address Classroom Challenges Due to the Impact of H1N1 Flu Virus 2Health News:Microsoft Gives Teachers Free Resources to Address Classroom Challenges Due to the Impact of H1N1 Flu Virus 3Health News:IH Systems RIVA Top Pick for Directors of Pharmacy 2Health News:Congress Breathes Easier, Thanks to Speaker Pelosi's Successful Efforts to Eliminate House Smoking Rooms 2Health News:FDA Requires Boxed Warning for Promethazine Hydrochloride Injection 2